Cellivery Therapeutics
₩16
0
+₩0+0%Thursday 06:00
Statistics
Day High
25
Day Low
15
52W High
6,680
52W Low
0
Volume
67,284,258
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Earnings
Mar 22Expected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-491
-484
-477
-469
Expected EPS
N/A
Actual EPS
N/A
Financials
-324.54%Profit Margin
Unprofitable23.16BRevenue
-75.16BNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Cellivery Therapeutics, Inc. is dedicated to pioneering therapeutic drugs designed to combat critical and often fatal conditions, including various cancers, inflammatory disorders, metabolic diseases, and neurodegenerative ailments. The company leverages its proprietary Therapeutic molecule Systemic Delivery Technology to develop a diverse pipeline of small molecule compounds, antibodies, and vaccines. Established in 2014, this firm is headquartered in Seoul, South Korea.
Show More
CEO
Daewoong Jo
Employees
22
Country
South Korea
ISIN
KR7268600004
Listings
0 Comments
Share your thoughts
FAQs
What is Cellivery Therapeutics stock price today?▼
The current price of 268600.KQ is ₩16 KRW — it has increased by +0% in the past 24 hours. Watch Cellivery Therapeutics stock price performance more closely on the chart.
What is Cellivery Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on KOSDAQ exchange Cellivery Therapeutics stocks are traded under the ticker 268600.KQ.
What is Cellivery Therapeutics revenue for the last year?▼
Cellivery Therapeutics revenue for the last year amounts to 23.16B KRW.
What is Cellivery Therapeutics net income for the last year?▼
268600.KQ net income for the last year is -75.16B KRW.
How many employees does Cellivery Therapeutics have?▼
As of November 4, 2026, the company has 22 employees.
In which sector is Cellivery Therapeutics located?▼
Cellivery Therapeutics operates in the Health & Wellness sector.
When did Cellivery Therapeutics complete a stock split?▼
The last stock split for Cellivery Therapeutics was on July 25, 2022 with a ratio of 1:1.
Where is Cellivery Therapeutics headquartered?▼
Cellivery Therapeutics is headquartered in Seoul, South Korea.